173 related articles for article (PubMed ID: 34388365)
1. Progesterone receptor-DNA methylation crosstalk regulates depletion of uterine leiomyoma stem cells: A potential therapeutic target.
Liu S; Yin P; Xu J; Dotts AJ; Kujawa SA; Coon V JS; Zhao H; Dai Y; Bulun SE
Stem Cell Reports; 2021 Sep; 16(9):2099-2106. PubMed ID: 34388365
[TBL] [Abstract][Full Text] [Related]
2. Targeting DNA Methylation Depletes Uterine Leiomyoma Stem Cell-enriched Population by Stimulating Their Differentiation.
Liu S; Yin P; Xu J; Dotts AJ; Kujawa SA; Coon V JS; Zhao H; Shilatifard A; Dai Y; Bulun SE
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32812024
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma.
Liu S; Yin P; Kujawa SA; Coon JS; Okeigwe I; Bulun SE
Oncogene; 2019 Apr; 38(15):2722-2735. PubMed ID: 30538295
[TBL] [Abstract][Full Text] [Related]
4. Uterine Leiomyoma Stem Cells: Linking Progesterone to Growth.
Bulun SE; Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Zhao H; Maruyama T; Chakravarti D; Kim JJ; Wei JJ
Semin Reprod Med; 2015 Sep; 33(5):357-65. PubMed ID: 26251118
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.
Yin P; Roqueiro D; Huang L; Owen JK; Xie A; Navarro A; Monsivais D; Coon JS; Kim JJ; Dai Y; Bulun SE
PLoS One; 2012; 7(1):e29021. PubMed ID: 22272226
[TBL] [Abstract][Full Text] [Related]
6. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
[TBL] [Abstract][Full Text] [Related]
7. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.
Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Chakravarti D; Kim JJ; Wei JJ; Bulun SE
Hum Reprod Update; 2015; 21(1):1-12. PubMed ID: 25205766
[TBL] [Abstract][Full Text] [Related]
8. PLIN2 Functions As a Novel Link Between Progesterone Signaling and Metabolism in Uterine Leiomyoma Cells.
Okeigwe I; Bulun S; Liu S; Rademaker AW; Coon JS; Kujawa S; Robins J; Yin P
J Clin Endocrinol Metab; 2019 Dec; 104(12):6256-6264. PubMed ID: 31504629
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.
Yin P; Lin Z; Reierstad S; Wu J; Ishikawa H; Marsh EE; Innes J; Cheng Y; Pearson K; Coon JS; Kim JJ; Chakravarti D; Bulun SE
Cancer Res; 2010 Feb; 70(4):1722-30. PubMed ID: 20124487
[TBL] [Abstract][Full Text] [Related]
10. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
11. Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo.
Yin P; Ono M; Moravek MB; Coon JS; Navarro A; Monsivais D; Dyson MT; Druschitz SA; Malpani SS; Serna VA; Qiang W; Chakravarti D; Kim JJ; Bulun SE
J Clin Endocrinol Metab; 2015 Apr; 100(4):E601-6. PubMed ID: 25658015
[TBL] [Abstract][Full Text] [Related]
12. [The molecular mechanisms and morphological manifestations of leiomyoma reduction induced by selective progesterone receptor modulators].
Demura TA; Revazova ZV; Kogan EA; Adamyan LV
Arkh Patol; 2017; 79(3):19-26. PubMed ID: 28631712
[TBL] [Abstract][Full Text] [Related]
13. Hormones and pathogenesis of uterine fibroids.
Reis FM; Bloise E; Ortiga-Carvalho TM
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():13-24. PubMed ID: 26725037
[TBL] [Abstract][Full Text] [Related]
14. The role of progesterone signaling in the pathogenesis of uterine leiomyoma.
Kim JJ; Sefton EC
Mol Cell Endocrinol; 2012 Jul; 358(2):223-31. PubMed ID: 21672608
[TBL] [Abstract][Full Text] [Related]
15. Roles of progesterone receptor A and B isoforms during human endometrial decidualization.
Kaya HS; Hantak AM; Stubbs LJ; Taylor RN; Bagchi IC; Bagchi MK
Mol Endocrinol; 2015 Jun; 29(6):882-95. PubMed ID: 25875046
[TBL] [Abstract][Full Text] [Related]
16. 5-aza-2'-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt/β-catenin pathway in human uterine leiomyomas.
Carbajo-García MC; Corachán A; Segura-Benitez M; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
Reprod Biol Endocrinol; 2021 Jul; 19(1):106. PubMed ID: 34233687
[TBL] [Abstract][Full Text] [Related]
17. Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.
Wu X; Serna VA; Thomas J; Qiang W; Blumenfeld ML; Kurita T
Cancer Res; 2017 Dec; 77(24):6891-6901. PubMed ID: 29055020
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles.
Carbajo-García MC; Corachán A; Juárez-Barber E; Monleón J; Payá V; Trelis A; Quiñonero A; Pellicer A; Ferrero H
J Pathol; 2022 Aug; 257(5):663-673. PubMed ID: 35472162
[TBL] [Abstract][Full Text] [Related]
19. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism.
Zhang L; Feng Q; Wang Z; Liu P; Cui S
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
